Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00336700
Status:
TERMINATED
Last Update Posted:
2016-09-19
First Post:
2006-06-12
Brief Title:
A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer
Sponsor:
Herbert J Zeh III MD FACS
Organization:
University of Pittsburgh
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-06
Start Date Type:
None
Primary Completion Date:
2011-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-11
Completion Date Type:
ACTUAL
First Submit Date:
2006-06-12
First Submit QC Date:
June 12 2006
Study First Post Date:
2006-06-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2016-09-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-07-27
Last Update Post Date:
2016-09-19
Last Update Post Date Type:
ESTIMATED